Simon Kaja, Ph.D.
Job title: Chief Scientific Officer
Dr. Simon Kaja serves as Chief Scientific Officer and Vice-President, Americas of Experimentica Ltd., a global preclinical contract research organization specialized in ophthalmic indications.
Dr. Kaja received his undergraduate degree in Molecular Biology and Biochemistry from Durham University, UK and obtained his Ph.D. in Medicine from Leiden University, The Netherlands. He has held postdoctoral and researcher positions at The University of British Columbia, the University of North Texas Health Science Center at Fort Worth, Bayer AG, Novo Nordisk A/S, and NeuroSearch A/S. Immediately prior to joining Experimentica, Dr. Kaja served on the faculty of the University of Missouri – Kansas City.
Dr. Kaja is an internationally recognized expert in ocular drug discovery and development, author of more than 60 peer-reviewed publications, several book chapters and recipient of numerous grants and awards. In addition to his position at Experimentica, Dr. Kaja holds an appointment as Endowed Professor in Ophthalmology at Loyola University Chicago.
Advances in Preclinical Models for Angiogenesis and wet AMD 9:15 am
Preclinical models for angiogenesis and wet AMD Utility of in vivo imaging in the standardized assessment of AMD phenotypes in preclinical models for angiogenesis and wet AMD Advances in AI and machine learning for the unbiased analysis of data from preclinical studiesRead more
day: Day One